We believe that Merck KGaA enjoys a narrow moat, driven by intangible assets and switching costs which are prevalent in its Life Science and Electronics businesses. A few acquisitions to fill gaps in ...

which are not patent protected and now face generic competition; Assertio's ability to successfully identify and execute business development and other strategic transactions; Assertio's ability to ...

Ooops... Something went wrong while loading this page.